Recruiting phase 3 KRAS trials

Understood asView findTrials → table

5,123 trials match; 47 of those shown are recruiting or about to. NCT06592664 ↗ NCT07619417 ↗ NCT05494697 ↗ NCT07656376 ↗ NCT07619521 ↗ NCT07898813 ↗ +44 more below

Computed from the knowledge API (findTrials); every record links to its source.

Trial	Phase	Outcome	Status	Start	Sponsor
NCT06592664 ↗ Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC	Phase 1 / Phase 2	Stopped early	Withdrawn	2030-01	Lisata Therapeutics, Inc.
NCT07619417 ↗ Endoscopic Ultrasound-Guided Pulsed Electric Field Ablation for the Treatment of Pancreatic Neoplas…	NA	Ongoing	Enrolling by invitation	2027-10	The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
NCT05494697 ↗ Ampligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPC	Phase 2	Stopped early	Suspended	2027-08	AIM ImmunoTech Inc.
NCT07656376 ↗ Clinical Trial of DN022150 Combined With AG Chemotherapy as First-line Treatment for Locally Advanc…	Phase 2 / Phase 3	Ongoing